RMD - ResMed - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7611521078

Portable Diagnostics, Sleep Therapy Devices, Cloud-Based Software Applications

ResMed Inc. is a leading medical technology company that specializes in developing, manufacturing, and distributing innovative devices and cloud-based software solutions for the healthcare industry.

The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its Sleep and Respiratory Care segment offers a range of products and solutions for respiratory disorders, including portable diagnostic devices like ApneaLink Air and NightOwl, which measure various health metrics to diagnose and monitor sleep apnea and other respiratory conditions.

In addition to its diagnostic devices, ResMed provides a suite of cloud-based software applications that enable remote monitoring, patient engagement, and therapy management. For instance, its AirView system allows healthcare professionals to remotely monitor patients' device settings, while its myAir application provides personalized support and education to patients with sleep apnea.

ResMed's Software as a Service segment offers a range of out-of-hospital software solutions, including Brightree business management software, MatrixCare care management solutions, HEALTHCAREfirst electronic health record and billing services, and MEDIFOX DAN's software solutions. These solutions cater to various healthcare providers, including home medical equipment (HME) providers, senior living communities, home health and hospice organizations, and accountable care organizations.

The company's software solutions aim to streamline clinical and business operations, improve patient outcomes, and enhance the overall quality of care. By providing a comprehensive suite of products and solutions, ResMed enables healthcare professionals to deliver more efficient, effective, and patient-centered care.

With a strong global presence, ResMed markets its products and solutions through a network of distributors and direct sales force, serving sleep clinics, home healthcare dealers, and hospitals worldwide. Founded in 1989, the company is headquartered in San Diego, California, and has established itself as a leader in the medical technology industry.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for RMD - ResMed  - Stock Price & Dividends

RMD Stock Overview

Market Cap in USD 35,966m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1995-06-02

RMD Stock Ratings

Growth 5y 48.3
Fundamental 89.9
Dividend 49.0
Rel. Performance vs Sector 1.45
Analysts 3.86/5
Fair Price Momentum 252.72 USD
Fair Price DCF 218.41 USD

RMD Dividends

Dividend Yield 12m 0.83%
Yield on Cost 5y 1.59%
Dividends CAGR 5y 3.90%
Payout Consistency 100.0%

RMD Growth Ratios

Growth 12m 66.06%
Growth Correlation 12m 92.8%
Growth Correlation 3m 80.2%
CAGR 5y 13.86%
CAGR/Mean DD 5y 0.72
Sharpe Ratio 12m 1.63
Alpha vs SP500 12m 33.76
Beta vs SP500 5y weekly 0.94
ValueRay RSI 31.26
Volatility GJR Garch 1y 34.01%
Price / SMA 50 0.95%
Price / SMA 200 16.62%
Current Volume 749.7k
Average Volume 20d 1055.5k

External Links for RMD Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of RMD stocks?
As of October 10, 2024, the stock is trading at USD 237.04 with a total of 749,689 shares traded.
Over the past week, the price has changed by -0.76%, over one month by -5.02%, over three months by +24.84% and over the past year by +75.72%.
What are the forecast for RMD stock price target?
According to ValueRays Forecast Model, RMD ResMed will be worth about 279.7 in October 2025. The stock is currently trading at 237.04. This means that the stock has a potential upside of +17.98%.
Issuer Forecast Upside
Wallstreet Target Price 226.9 -4.28
Analysts Target Price 184 -22.4
ValueRay Target Price 279.7 18.0